BRCA2 and prostate carcinoma: The male BRCA2 PV carrier CBC SIR was greater than the corresponding HR, indicating that FH may partly account for the elevated risk, consistent with previous research.28 The prostate cancer SIR was consistent with previous research,29 and similar to the corresponding HR.